Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
16 hedge funds and large institutions have $7.7M invested in Acer Therapeutics Inc in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
96,100% more capital invested
Capital invested by funds: $8K → $7.7M (+$7.69M)
300% more funds holding
Funds holding: 4 → 16 (+12)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$2.44M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$1.76M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.63M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$1.48M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$554 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $2.09M | +$2.44M | +150,000 | New |
|
|
JGC
2
J. Goldman & Co
New York
| $1.5M | +$1.76M | +108,000 | New |
|
|
SCM
3
Stonepine Capital Management
Bend,
Oregon
| $1.39M | +$1.63M | +100,000 | New |
|
|
PVI
4
Pura Vida Investments
New York
| $1.26M | +$1.48M | +90,660 | New |
|
|
5
Alyeska Investment Group
Chicago,
Illinois
| $1.04M | +$1.22M | +75,000 | New |
|
|
AAP
6
Ardsley Advisory Partners
Stamford,
Connecticut
| $212K | +$249K | +15,300 | New |
|
7
Wells Fargo
San Francisco,
California
| $79K | +$92.9K | +5,705 | New |
|
8
First Manhattan
New York
| $69K | +$81.4K | +5,000 | New |
|
9
Macquarie Group
Sydney, NSW 2000,
Australia
| $36K | +$42.3K | +2,600 | New |
|
10
UBS Group
Zurich,
Switzerland
| $19K | +$21.8K | +1,337 | New |
|
11
JP Morgan Chase
New York
| $9K | +$10.5K | +645 | New |
|
12
BlackRock
New York
| $5K | – | – | – |
|
|
13
Morgan Stanley
New York
| – | -$554 | -34 | -87% |
|
14
Bank of America
Charlotte,
North Carolina
| – | +$195 | +12 | New |
|
ACER Hedge Fund Activity: Q4 2017 in Review
16 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2017, worth a combined $7.7M — up 96,100% from $8K a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACER positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.44M. The largest seller was Morgan Stanley, cutting an estimated $554.
- 16 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2017, up from 4 in Q3 2017.
- Funds reported $7.7M of Acer Therapeutics Inc stock for Q4 2017, up 96,100% quarter-over-quarter.
- 12 funds opened new Acer Therapeutics Inc positions in Q4 2017 and 0 closed out, a net change of +12 holders.
- The largest Acer Therapeutics Inc buyer in Q4 2017 was Perceptive Advisors, an estimated $2.44M added.
- The largest Acer Therapeutics Inc seller in Q4 2017 was Morgan Stanley, an estimated $554 sold.
Based on aggregated 13F filings for Q4 2017.